<DOC>
	<DOCNO>NCT01870518</DOCNO>
	<brief_summary>Purpose : This prospective single-center , randomize , patient evaluator-blind clinical trial compare neurocognitive outcome globus pallidus interna ( GPi ) versus subthalamic nucleus ( STN ) deep brain stimulation ( DBS ) Parkinson 's disease ( PD ) patient mild cognitive impairment ( MCI ) .</brief_summary>
	<brief_title>Neurocognitive Effects Bilateral STN Versus GPi DBS Parkinson 's Disease Patients With MCI</brief_title>
	<detailed_description>Deep brain stimulation ( DBS ) globus pallidus interna ( GPi ) subthalamic nucleus ( STN ) accept surgical treatment choice patient advance Parkinson 's Disease ( PD ) , demonstrate improvement motor function exceed achieve medical management alone . Unfortunately , paucity data exist compare non-motor outcome DBS available target . Specifically , high prevalence concurrent cognitive dysfunction early dementia exists PD patient , unclear whether DBS target selection may differential effect regard cognitive outcome PD patient early evidence mild cognitive impairment Previous study indicate stimulation either GPi STN associate decrement patient ' verbal fluency , visuospatial memory , well overall cognitive decline , patient randomize without consideration baseline neurocognitive performance unclear whether effect due treatment rather natural history patient . In addition clinical arm trial , another secondary goal evaluate several biomarkers obtain blood cerebrospinal order determine utility prognosticator patient cognitive motor outcome . Specifically , evaluate level amyloid 1-42 , total tau , phosphorylated tau 181 , brain derive neurotrophic factor cerebrospinal fluid well genotyping apolipoprotein-E gene . These protein genotype still currently investigation potential biomarkers dementia well neuroplasticity .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>clinical diagnosis idiopathic Parkinson 's disease deem appropriate candidate DBS surgery Montreal Cognitive Assessment ( MoCA ) score &lt; 25 Neuropsychological test diagnosis Mild Cognitive Impairment diagnosis Parkinson 's disease appropriate DBS surgery</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Dementia</keyword>
</DOC>